Read More Pharma Industry News UCB announces positive 48-week results for BIMZELX in Hidradenitis Suppurativa studies At the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego, California, UCB, a leading global… byPallavi MadhirajuMarch 9, 2024